VTVT vTv Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: VTVT

Price (delayed)

$23.63

Market cap

$71.13M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$9.71

Enterprise value

$62.21M

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by programs for the treatment ...

Highlights
VTVT's debt is down by 38% since the previous quarter and by 26% year-on-year
The company's EPS rose by 6% QoQ and by 2.7% YoY
VTVT's equity has dropped by 130% year-on-year but it is up by 2.2% since the previous quarter
The quick ratio has plunged by 72% YoY but it has increased by 13% from the previous quarter
vTv Therapeutics's gross profit has plunged by 100% from the previous quarter and by 100% YoY
vTv Therapeutics's revenue has plunged by 100% from the previous quarter and by 100% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.vtvtherapeutics.com
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of VTVT
Market
Shares outstanding
3.01M
Market cap
$71.13M
Enterprise value
$62.21M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$20.24M
EBITDA
-$20.15M
Free cash flow
-$19.08M
Per share
EPS
-$9.71
Free cash flow per share
-$7.3
Book value per share
-$9.44
Revenue per share
$0
TBVPS
$4.21
Balance sheet
Total assets
$11.02M
Total liabilities
$29.57M
Debt
$529,000
Equity
-$24.68M
Working capital
$38,000
Liquidity
Debt to equity
-0.02
Current ratio
1
Quick ratio
0.9
Net debt/EBITDA
0.44
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-104.9%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-5,071.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

VTVT stock price

How has the vTv Therapeutics stock price performed over time
Intraday
1.03%
1 week
-11.86%
1 month
-5.67%
1 year
-26.17%
YTD
105.48%
QTD
0.42%

Financial performance

How have vTv Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$24.93M
Net income
-$20.25M
Gross margin
N/A
Net margin
N/A
vTv Therapeutics's gross profit has plunged by 100% from the previous quarter and by 100% YoY
vTv Therapeutics's revenue has plunged by 100% from the previous quarter and by 100% YoY
VTVT's operating income is down by 15% YoY but it is up by 3.3% QoQ
The net income is up by 6% since the previous quarter but it has declined by 6% year-on-year

Growth

What is vTv Therapeutics's growth rate over time

Valuation

What is vTv Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 6% QoQ and by 2.7% YoY
VTVT's equity has dropped by 130% year-on-year but it is up by 2.2% since the previous quarter
vTv Therapeutics's revenue has plunged by 100% from the previous quarter and by 100% YoY

Efficiency

How efficient is vTv Therapeutics business performance
vTv Therapeutics's return on assets has shrunk by 72% YoY and by 21% QoQ

Dividends

What is VTVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VTVT.

Financial health

How did vTv Therapeutics financials performed over time
VTVT's total assets is 63% smaller than its total liabilities
The current ratio has dropped by 72% year-on-year
The quick ratio has plunged by 72% YoY but it has increased by 13% from the previous quarter
VTVT's debt is 102% greater than its equity
VTVT's equity has dropped by 130% year-on-year but it is up by 2.2% since the previous quarter
The debt to equity has soared by 71% year-on-year and by 33% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.